15-Year watch: tracking gene Therapy's hidden risks in childhood cancer survivors
NCT ID NCT02315599
Summary
This study aims to monitor children and young adults for potential delayed side effects over 15 years after they received experimental gene therapy for cancer. Researchers will track up to 500 participants who were treated at the National Cancer Institute, checking their health regularly through blood tests, exams, and questionnaires. The goal is to understand the long-term safety of these advanced cancer treatments to better protect future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.